A Chinese biotech company is angling to buy California-based Complete Genomics, but federal regulators are expressing security concerns and may scuttle the deal.
A Chinese biotech company is angling to buy California-based Complete Genomics, but federal regulators are expressing security concerns and may scuttle the deal.
The US Food and Drug Administration is taking steps to get new devices on the market sooner—and antibiotics may be next.
The Supreme Court agrees to hear a case deciding if two cancer genes should continue to be protected by patent.
Undergraduate students delve into genomics and synthetic biology thanks to a new breed of technologically advanced courses.
Undergraduates and others are delving into modern genetics and genomics technologies in classrooms across the country.
The poxvirus stockpiles genes when it needs to adapt.
Without publishing any data, a Texas-based forensic company claims to have sequenced the genome of Bigfoot.
Three-dimensional genome maps are leading to a deeper understanding of how the genome’s form influences its function.
An all-female species, distantly related to flatworms, steals all of genetic material it needs to diversify its genome.
The crucial importance of language in the debate over the regulation of direct-to-consumer genetic tests